remimazolam and Takayasu-Arteritis

remimazolam has been researched along with Takayasu-Arteritis* in 1 studies

Other Studies

1 other study(ies) available for remimazolam and Takayasu-Arteritis

ArticleYear
Total Intravenous Anesthesia Using Remimazolam and Continuous Cardiac Output Monitoring for Dental Anesthesia in a Patient With Takayasu's Arteritis: A Case Report.
    A&A practice, 2022, Aug-01, Volume: 16, Issue:8

    Takayasu's arteritis is a persistent chronic progressive inflammation of the large- and medium-caliber arteries. Controlling cardiovascular variability during anesthesia and overcoming difficulties of cardiovascular monitoring due to the impaired vessels are important in patients with Takayasu's arteritis. Remimazolam is a novel short-acting benzodiazepine with mild effects on hemodynamics. We report the case of a patient with Takayasu's arteritis who underwent oral surgery under general anesthesia. This report highlights the use of remimazolam and remifentanil to reduce hemodynamic perturbations using estimated continuous cardiac output monitoring.

    Topics: Anesthesia, Dental; Anesthesia, General; Anesthesia, Intravenous; Benzodiazepines; Cardiac Output; Humans; Takayasu Arteritis

2022